---

$0.74

-0.0560 ( -7.00% ) 223.9K

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-10-04	Sale	-3059.00	Agafonova Nataliya
2023-10-04	Sale	-4078.00	Locklear Lisa
2023-10-04	Sale	-815.00	Lehr Paul T
2023-09-22	Sale	-5000.00	Hare Joshua
2023-09-21	Sale	-2000.00	Lehr Paul T
2023-09-14	Sale	-30000.00	Hare Joshua
2023-09-13	Sale	-30000.00	Hare Joshua
2023-09-13	Buy	5000.00	Locklear Lisa
2023-09-13	Sale	-10000.00	Hashad Mohamed Wa'el Ahmed
2023-09-12	Sale	-30000.00	Soffer Rock